According to Xenon Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -3,35ย โฌ. In 2024 the company made an earnings per share (EPS) of -2,60ย โฌ a decrease over its 2023 EPS that were of -2,34ย โฌ.